Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 566

1.

Probabilistic inversion of expert assessments to inform projections about Antarctic ice sheet responses.

Fuller RW, Wong TE, Keller K.

PLoS One. 2017 Dec 29;12(12):e0190115. doi: 10.1371/journal.pone.0190115. eCollection 2017.

2.

Deguelins, Natural Product Modulators of NF1-Defective Astrocytoma Cell Growth Identified by High-Throughput Screening of Partially Purified Natural Product Extracts.

Henrich CJ, Cartner LK, Wilson JA, Fuller RW, Rizzo AE, Reilly KM, McMahon JB, Gustafson KR.

J Nat Prod. 2015 Nov 25;78(11):2776-81. doi: 10.1021/acs.jnatprod.5b00753. Epub 2015 Oct 15.

3.

Inhibition of ABCG2-mediated drug efflux by naphthopyrones from marine crinoids.

Bokesch HR, Cartner LK, Fuller RW, Wilson JA, Henrich CJ, Kelley JA, Gustafson KR, McMahon JB, McKee TC.

Bioorg Med Chem Lett. 2010 Jul 1;20(13):3848-50. doi: 10.1016/j.bmcl.2010.05.057. Epub 2010 May 21.

4.

Isolation, structural elucidation, and absolute stereochemistry of enigmazole A, a cytotoxic phosphomacrolide from the Papua New Guinea marine sponge Cinachyrella enigmatica.

Oku N, Takada K, Fuller RW, Wilson JA, Peach ML, Pannell LK, McMahon JB, Gustafson KR.

J Am Chem Soc. 2010 Aug 4;132(30):10278-85. doi: 10.1021/ja1016766.

5.

Cough provocation tests: their clinical value.

Fuller RW.

Pulm Pharmacol Ther. 2002;15(3):273-6. Review.

PMID:
12099777
6.

Pharmacological regulation of the cough reflex--from experimental models to antitussive effects in Man.

Karlsson JA, Fuller RW.

Pulm Pharmacol Ther. 1999;12(4):215-28. Review. No abstract available.

PMID:
10500001
7.

Cytotoxic and tubulin-interactive hemiasterlins from Auletta sp. and Siphonochalina spp. sponges.

Gamble WR, Durso NA, Fuller RW, Westergaard CK, Johnson TR, Sackett DL, Hamel E, Cardellina JH 2nd, Boyd MR.

Bioorg Med Chem. 1999 Aug;7(8):1611-5.

PMID:
10482453
8.

Guttiferone F, the first prenylated benzophenone from Allanblackia stuhlmannii.

Fuller RW, Blunt JW, Boswell JL, Cardellina JH 2nd, Boyd MR.

J Nat Prod. 1999 Jan;62(1):130-2.

PMID:
9917299
9.

Vismiaphenones D-G, new prenylated benzophenones from Vismia cayennensis.

Fuller RW, Westergaard CK, Collins JW, Cardellina JH 2nd, Boyd MR.

J Nat Prod. 1999 Jan;62(1):67-9.

PMID:
9917284
10.

Pyranocoumarins from tropical species of the genus Calophyllum: a chemotaxonomic study of extracts in the National Cancer Institute collection.

McKee TC, Covington CD, Fuller RW, Bokesch HR, Young S, Cardellina II JH, Kadushin MR, Soejarto DD, Stevens PF, Cragg GM, Boyd MR.

J Nat Prod. 1998 Oct;61(10):1252-6.

PMID:
9784162
11.

The selective norepinephrine reuptake inhibitor, LY368975, reduces food consumption in animal models of feeding.

Gehlert DR, Dreshfield L, Tinsley F, Benvenga MJ, Gleason S, Fuller RW, Wong DT, Hemrick-Luecke SK.

J Pharmacol Exp Ther. 1998 Oct;287(1):122-7.

PMID:
9765330
12.
13.

Vasopressin/serotonin interactions in the anterior hypothalamus control aggressive behavior in golden hamsters.

Ferris CF, Melloni RH Jr, Koppel G, Perry KW, Fuller RW, Delville Y.

J Neurosci. 1997 Jun 1;17(11):4331-40.

16.

Structure-activity modifications of the HIV-1 inhibitors (+)-calanolide A and (-)-calanolide B.

Galinis DL, Fuller RW, McKee TC, Cardellina JH 2nd, Gulakowski RJ, McMahon JB, Boyd MR.

J Med Chem. 1996 Oct 25;39(22):4507-10.

PMID:
8893846
17.

Fluoxetine effects on serotonin function and aggressive behavior.

Fuller RW.

Ann N Y Acad Sci. 1996 Sep 20;794:90-7.

PMID:
8853595
18.

Involvement of 5-HT2A receptors in the elevation of rat serum corticosterone concentrations by quipazine and MK-212.

Hemrick-Luecke SK, Fuller RW.

Eur J Pharmacol. 1996 Sep 12;311(2-3):207-11.

PMID:
8891601
19.
20.

New pyranocoumarins isolated from Calophyllum lanigerum and Calophyllum teysmannii.

McKee TC, Fuller RW, Covington CD, Cardellina JH 2nd, Gulakowski RJ, Krepps BL, McMahon JB, Boyd MR.

J Nat Prod. 1996 Aug;59(8):754-8. Erratum in: J Nat Prod 1996 Nov;59(11):1108.

PMID:
8792623
21.

The asthma death problem revisited.

Fuller RW.

Br J Clin Pharmacol. 1996 Jul;42(1):11-4. Review.

22.

A comparison of the effects of an alpha-agonist, an anti-muscarinic agent and placebo on intranasal histamine challenge in allergic rhinitis.

Birchall MA, Henderson JC, Pride NB, Fuller RW.

Clin Otolaryngol Allied Sci. 1996 Jun;21(3):212-7.

PMID:
8818489
23.

Pharmacokinetics of intravenous fluticasone propionate in healthy subjects.

Mackie AE, Ventresca GP, Fuller RW, Bye A.

Br J Clin Pharmacol. 1996 Jun;41(6):539-42.

24.

Capsaicin cough sensitivity increases during upper respiratory infection.

O'Connell F, Thomas VE, Studham JM, Pride NB, Fuller RW.

Respir Med. 1996 May;90(5):279-86.

25.

Imaging allergen-invoked airway inflammation in atopic asthma with [18F]-fluorodeoxyglucose and positron emission tomography.

Taylor IK, Hill AA, Hayes M, Rhodes CG, O'Shaughnessy KM, O'Connor BJ, Jones HA, Hughes JM, Jones T, Pride NB, Fuller RW.

Lancet. 1996 Apr 6;347(9006):937-40.

PMID:
8598758
26.

Mechanisms and functions of serotonin neuronal systems: opportunities for neuropeptide interactions.

Fuller RW.

Ann N Y Acad Sci. 1996 Mar 22;780:176-84. Review. No abstract available.

PMID:
8602731
27.

Neurochemical evidence for antagonism by olanzapine of dopamine, serotonin, alpha 1-adrenergic and muscarinic receptors in vivo in rats.

Bymaster FP, Hemrick-Luecke SK, Perry KW, Fuller RW.

Psychopharmacology (Berl). 1996 Mar;124(1-2):87-94.

PMID:
8935803
28.

The influence of fluoxetine on aggressive behavior.

Fuller RW.

Neuropsychopharmacology. 1996 Feb;14(2):77-81. Review.

29.
30.

Dopamine and 5-HT receptor sensitivity does not correlate with neostriatal dopamine or 5-HT content.

Kostrzewa RM, Brus R, Perry KW, Fuller RW.

Acta Neurobiol Exp (Wars). 1996;56(1):21-8.

31.

Patient perception of the diskus inhaler: a comparison with the turbuhaler inhaler.

Schlaeppi M, Edwards K, Fuller RW, Sharma R.

Br J Clin Pract. 1996 Jan-Feb;50(1):14-9.

PMID:
8729596
32.

Serum corticosterone increases reflect enhanced uptake inhibitor-induced elevation of extracellular 5-hydroxytryptamine in rat hypothalamus.

Fuller RW, Perry KW, Hemrick-Luecke SK, Engleman E.

J Pharm Pharmacol. 1996 Jan;48(1):68-70.

PMID:
8722499
33.

Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered-dose inhaler (P-MDI)

Fuller RW, Sharma RK, Cripps A.

Eur Respir J. 1995 Dec;8(12):2194-5. No abstract available.

34.

Abnormal intraepithelial airway nerves in persistent unexplained cough?

O'Connell F, Springall DR, Moradoghli-Haftvani A, Krausz T, Price D, Fuller RW, Polak JM, Pride NB.

Am J Respir Crit Care Med. 1995 Dec;152(6 Pt 1):2068-75.

PMID:
8520777
35.
36.

Assessing equivalence of inhaled drugs.

Fuller RW, Hallett C, Dahl R.

Respir Med. 1995 Sep;89(8):525-7.

37.

Postoperative radiation therapy in clinical stage I endometrial cancer: corpus, cervical, and lower uterine segment involvement--patterns of failure.

Mayr NA, Wen BC, Benda JA, Sorosky JI, Davis CS, Fuller RW, Hussey DH.

Radiology. 1995 Aug;196(2):323-8.

PMID:
7617840
38.

Tissue distribution, metabolism and effects of bufotenine administered to rats.

Fuller RW, Snoddy HD, Perry KW.

Neuropharmacology. 1995 Jul;34(7):799-804.

PMID:
8532147
39.

Systemic effects of glucocorticoids--a response.

Fuller RW, Bye A, Baber NS.

Br J Clin Pharmacol. 1995 Jun;39(6):709-11. No abstract available.

40.

The effect of topical fluticasone propionate on intranasal histamine challenge in subjects with perennial allergic rhinitis.

Birchall MA, Henderson JC, Studham JM, Phillips I, Pride NB, Fuller RW.

Clin Otolaryngol Allied Sci. 1995 Jun;20(3):204-10.

PMID:
7554327
41.

Are there any detrimental effects of the use of inhaled long-acting beta 2-agonists in the treatment of asthma?

Devoy MA, Fuller RW, Palmer JB.

Chest. 1995 Apr;107(4):1116-24. Review. No abstract available.

PMID:
7705125
42.
43.

Decreased hypothalamic epinephrine concentration by quipazine and other serotonin agonists in rats.

Hemrick-Luecke SK, Fuller RW.

Biochem Pharmacol. 1995 Jan 31;49(3):323-7.

PMID:
7857319
44.
45.

Novel halogenated analogs of tomoxetine that are potent and selective inhibitors of norepinephrine uptake in brain.

Gehlert DR, Schober DA, Hemrick-Luecke SK, Krushinski J, Howbert JJ, Robertson DW, Fuller RW, Wong DT.

Neurochem Int. 1995 Jan;26(1):47-52.

PMID:
7787762
46.

(R)-thionisoxetine, a potent and selective inhibitor of central and peripheral norepinephrine uptake.

Gehlert DR, Hemrick-Luecke SK, Schober DA, Krushinski J, Howbert JJ, Robertson DW, Wong DT, Fuller RW.

Life Sci. 1995;56(22):1915-20.

PMID:
7746100
47.
48.

Comparison of desmethylsertraline with sertraline as a monoamine uptake inhibitor in vivo.

Fuller RW, Hemrick-Luecke SK, Littlefield ES, Audia JE.

Prog Neuropsychopharmacol Biol Psychiatry. 1995 Jan;19(1):135-49.

PMID:
7535937
49.

Isolation and structure/activity features of halomon-related antitumor monoterpenes from the red alga Portieria hornemannii.

Fuller RW, Cardellina JH 2nd, Jurek J, Scheuer PJ, Alvarado-Lindner B, McGuire M, Gray GN, Steiner JR, Clardy J, Menez E, et al.

J Med Chem. 1994 Dec 9;37(25):4407-11.

PMID:
7996553
50.

The effect of topical sodium cromoglycate on intranasal histamine challenge in allergic rhinitis.

Birchall MA, Henderson JC, Studham JM, Pride NB, Fuller RW.

Clin Otolaryngol Allied Sci. 1994 Dec;19(6):521-5.

PMID:
7895384

Supplemental Content

Loading ...
Support Center